Mitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: Implications for breast Cancer
Authors:
- Suvajit SenSSSuvajit Sen
- Brian KawaharaBKBrian Kawahara
- Gautam ChaudhuriGCGautam Chaudhuri
- 1 April 2013
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 57, 210-220
Abstract
No abstract availableKeywords
Funding Information
- Carl and Roberta Deutsch Foundation and Kelly Day
This publication has 28 references indexed in Scilit:
- Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancerTrends in Pharmacological Sciences, 2011
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapyOncogene, 2011
- Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patientsJournal of Clinical Investigation, 2010
- Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen speciesFree Radical Biology and Medicine, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Repetitive Ischemia by Coronary Stenosis Induces a Novel Window of Ischemic PreconditioningCirculation, 2008
- Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopyNature Protocols, 2007
- Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell linesBreast Cancer Research and Treatment, 1996
- Nitric Oxide Potently and Reversibly Deenergizes Mitochondria at Low Oxygen TensionBiochemical and Biophysical Research Communications, 1994
- Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxideFEBS Letters, 1994